NCT00376064 - Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2010

Conditions

Acromegaly

Interventions

DRUG

Octreotide acetate and cabergoline/Octrotide and Somavert

Trial Locations (16)

Novartis Investigative Site, Aachen

Novartis Investigative Site, Berlin

Novartis Investigative Site, Bochum

Novartis Investigative Site, Cologne

Novartis Investigative Site, Erlangen

Novartis Investigative Site, Essen

Novartis Investigative Site, Greifswald

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Marburg

Novartis Investigative Site, München

Novartis Investigative Site, Oldenburg

Novartis Investigative Site, Regensburg

Novartis Investigative Site, Tübingen

Novartis Investigative Site, Ulm

Novartis Investigative Site, Würzburg